IQOS Together X Brand Event Celebrates 10th Anniversary in Japan

Events by 2FIRSTS.ai
May.23.2024
IQOS Together X Brand Event Celebrates 10th Anniversary in Japan
Philip Morris Japan hosted the "IQOS Together X" event in Tokyo to celebrate the 10th anniversary of IQOS in Japan.

According to the Japanese media Sanspo, on May 22nd, Philip Morris Japan held a large-scale brand event called "IQOS Together X" in front of the Meiji Shrine in Tokyo.

 

The event was organized to commemorate the 10th anniversary of the company's heated tobacco product "IQOS" being launched in Japan. Smokers over the age of 20 are welcome to participate, even if they are not IQOS users. After registering as a member on a dedicated website, participants can earn points to enter a draw by watching videos and completing surveys.

 

The event will be held four times from May to September. The highlight of the first round (ending on June 22) is the "Ultimate Mediterranean Greek Experience" for 10 people for 7 days and 5 nights. In addition, a total of 180,000 prizes will be distributed in four rounds to express gratitude to IQOS users and encourage them to quit smoking.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss
U.S. Court Rules Zyn Marketing Dispute Can Proceed, Rejects Philip Morris International’s Bid to Dismiss
A U.S. federal court in Florida denied Philip Morris International and its subsidiaries’ motion to dismiss, allowing consumers to proceed with claims under the Florida Deceptive and Unfair Trade Practices Act alleging that Zyn nicotine pouches’ “tobacco-free” marketing is misleading. The court held that the allegations do not amount to a fraud claim and may move forward to the merits stage.
Dec.15 by 2FIRSTS.ai
South Korea to Classify Synthetic Nicotine E-Cigarettes as Tobacco from April 2026
South Korea to Classify Synthetic Nicotine E-Cigarettes as Tobacco from April 2026
South Korea will implement amendments to its Tobacco Business Act on April 24, 2026, officially classifying synthetic nicotine liquid e-cigarettes as tobacco. This marks the first revision of the legal definition of tobacco since 1988. Once in effect, synthetic nicotine e-cigarettes will be subject to existing tobacco regulations, including health warnings, advertising restrictions, smoke-free area enforcement, and youth protection measures.
Dec.29 by 2FIRSTS.ai
Smoore International Donates $5 Million Hong Kong Dollars to Big Fire Disaster Area for Medical Aid and Relief
Smoore International Donates $5 Million Hong Kong Dollars to Big Fire Disaster Area for Medical Aid and Relief
Smoore International donates HK$5 million to aid Big Bay fire victims, marking its first charity donation in 2025.
Nov.28 by 2FIRSTS.ai
Energy Marketers of America Backs White House Crackdown on Illicit Vape Shops, Urges Cleanup of ‘Gray Area’ Market
Energy Marketers of America Backs White House Crackdown on Illicit Vape Shops, Urges Cleanup of ‘Gray Area’ Market
The Energy Marketers of America (EMA) has publicly endorsed the White House’s enforcement campaign against illicit vape shops, saying it will help address the regulatory “gray area” that has emerged since 2020 due to delayed product approvals. EMA noted that a large volume of unauthorized imported disposable e-cigarettes worth about $86.5 million has been seized and called for stronger, more localized enforcement efforts to ease the burden on compliant convenience retailers.
Dec.04 by 2FIRSTS.ai
Japan Tobacco Announces Executive Leadership Changes Effective in 2026
Japan Tobacco Announces Executive Leadership Changes Effective in 2026
Japan Tobacco Inc. (JT) has announced a series of executive and board appointments effective from 2026, including the nomination of Takehiko Tsutsui—currently Executive Vice President at JT International—as President, CEO and Representative Director.
Nov.26
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20